Skip to search formSkip to main contentSkip to account menu

Diclofenac Topical Gel [Solaraze]

National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Diclofenac Sodium 0.03 MG/MG Topical Gel [Solaraze]
SolarazeTopical Gel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A case of Solaraze™ (3% Diclofenac Sodium/ Hyaluronic Acid) Gel applied to primary cutaneous squamous cell carcinoma
Review
2003
Review
2003
New Approaches to the Treatment of Actinic Keratosis
Actinic keratoses are hyperkeratotic skin lesions that represent focal abnormal proliferation of epidermal keratinocytes. The… 
2003
2003
Spotlight on Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel
Topical 3% diclofenac in 2.5% hyaluronic acid (HA) gel (diclofenac HA gel; Solaraze™) is an NSAID approved for the treatment of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)